Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

391 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit.
Wheatley-Price P, Ma C, Ashcroft LF, Nankivell M, Stephens RJ, White SC, Lorigan P, Thatcher N, Blackhall FH, Shepherd FA. Wheatley-Price P, et al. Among authors: thatcher n. Ann Oncol. 2010 Feb;21(2):232-237. doi: 10.1093/annonc/mdp300. Epub 2009 Aug 12. Ann Oncol. 2010. PMID: 19675093 Free article.
Gefitinib for the treatment of non-small-cell lung cancer.
Campbell L, Blackhall F, Thatcher N. Campbell L, et al. Among authors: thatcher n. Expert Opin Pharmacother. 2010 Jun;11(8):1343-57. doi: 10.1517/14656566.2010.481283. Expert Opin Pharmacother. 2010. PMID: 20426712 Review.
Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter randomized LU21 trial.
Thatcher N, Qian W, Clark PI, Hopwood P, Sambrook RJ, Owens R, Stephens RJ, Girling DJ. Thatcher N, et al. J Clin Oncol. 2005 Nov 20;23(33):8371-9. doi: 10.1200/JCO.2004.00.9969. J Clin Oncol. 2005. PMID: 16293867 Clinical Trial.
Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer Working Party.
Thatcher N, Girling DJ, Hopwood P, Sambrook RJ, Qian W, Stephens RJ. Thatcher N, et al. J Clin Oncol. 2000 Jan;18(2):395-404. doi: 10.1200/JCO.2000.18.2.395. J Clin Oncol. 2000. PMID: 10637255 Clinical Trial.
Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status </= 70) and advanced non-small-cell lung cancer.
Baka S, Ashcroft L, Anderson H, Lind M, Burt P, Stout R, Dowd I, Smith D, Lorigan P, Thatcher N. Baka S, et al. Among authors: thatcher n. J Clin Oncol. 2005 Apr 1;23(10):2136-44. doi: 10.1200/JCO.2005.01.003. Epub 2005 Feb 14. J Clin Oncol. 2005. PMID: 15713598 Clinical Trial.
Management of small-cell lung cancer.
Thatcher N, Faivre-Finn C, Lorigan P. Thatcher N, et al. Ann Oncol. 2005;16 Suppl 2:ii235-9. doi: 10.1093/annonc/mdi700. Ann Oncol. 2005. PMID: 15958464 Free article. Review. No abstract available.
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1).
Booton R, Lorigan P, Anderson H, Baka S, Ashcroft L, Nicolson M, O'Brien M, Dunlop D, O'Byrne K, Laurence V, Snee M, Dark G, Thatcher N. Booton R, et al. Among authors: thatcher n. Ann Oncol. 2006 Jul;17(7):1111-9. doi: 10.1093/annonc/mdl078. Epub 2006 Apr 7. Ann Oncol. 2006. PMID: 16603599 Free article. Clinical Trial.
391 results